Laboratorios Farmaceuticos Rovi's total assets for Q4 2024 were €832.02M, a decrease of -5.22% from the previous quarter. ES:ROVI total liabilities were €250.48M for the fiscal quarter, a -21.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.